MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.
Welcome
Healthcare is steadily marching into a digital realm: digital healthcare, digital healthtech, and digital medicine. While we hear a lot about the first two, popular media is being less loud about digital medicine.
Some people think that digital medicine is akin to e-prescribing or medication prescribed during a VirtualCare visit. In reality, digital medicine is a field focused on the use of technologies as tools for measurement, and intervention in the service of human health. Digital medicine products are driven by high-quality hardware and software that support the practice of medicine broadly, including treatment, recovery, disease prevention, and health promotion for individuals and across populations. Digital medicine products are evidence-based tools that support the practice of medicine.
Digital medicine solutions track health information and collect or measure health data that can be used to manage a health condition. Examples of digital medicine solutions include:
It is important to note that other wearable devices, such as the Fitbit or Apple Watch are not considered digital medicine tools or medical devices because they aren’t intended for medical diagnosis and they did not receive FDA approval, only FDA ‘clearance’. Furthermore, some features, such as a blood oxygen monitor in Apple Watch, require neither a clearance nor an approval, since they are marketed as ‘wellness tools’.
An evolving development in digital medicine are digital pills (DP). Digital pills are designed to digitally track if patients have ingested their prescription medications in an effort to ensure medication adherence, and in some cases it also monitors health-related lifestyle habits.
DP consists of three complementary elements: an ingestible sensor, a wearable patch and a mobile application connected to an external web server. Once a patient swallows a pill with an ingestible sensor, the sensor sends a signal to a wearable patch which transmits data to a web-based portal, making the data available to the circle of care, the patient, and the healthcare provider.
Digital pills are designed to improve medication adherence, however, there are many concerns with privacy and ethics surrounding digital pills.
The same individuals that practice traditional medicine practice digital medicine: pharmacists, physicians, nurses, and health investigators. Some field experts include medical researchers who study behavioural and population health on the list.
To conclude, digital medicine uses technology for different purposes. It gives patients more control of their healthcare, for example, glucose monitoring devices allow patients to track sugar levels and inject themselves with insulin when needed. Digital pills, on the other hand, provide extra support to patients who need it. All in all, digital medicine complements traditional healthcare practices and allows a continuity of care beyond a clinician’s office, however, it still gives rise to privacy issues and ethical considerations.
MDBriefCase offers leading continuing medication courses for physicians, pharmacists, and nurses, including a digital medicine course on Glucose Monitoring: Optimizing Diabetes Care and Management. Explore more MDBriefCase diabetes management courses with a free MDBriefCase account:
For pharmacists: Advances in Insulin and Glucose Monitoring Technology Over the Last Century
For physicians: Advances in Blood Glucose Monitoring and Insulin Delivery
MDBriefCase is a member of the Think Research family of companies.
199 Bay Street #4000, Toronto,
ON M5L 1A9
In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:
Review: MDBriefCase is pleased to consider the publication of Your Work on the Website. The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.
Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered. If posted, You will be identified as the author of the Work, or co-author if applicable.
Grant of Rights: As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats: (1) the exclusive right of first publication worldwide; (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications. The grant of rights survives termination or expiration of this Agreement.
Warranty: You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work. This warranty survives termination or expiration of this Agreement.
Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.
The Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished. When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.
Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.
Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words.
MDBriefCase reserves the right to accept or reject any submission and the right to condition acceptance upon revision of material to conform to its criteria.
There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal websites, corporate websites and social media platforms.
Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.
